Department of Chemistry , George Washington University , Washington , D.C. 20052 , United States.
UES, Inc. , Dayton , Ohio 45432 , United States.
Anal Chem. 2019 Mar 19;91(6):3951-3958. doi: 10.1021/acs.analchem.8b05074. Epub 2019 Mar 4.
Silicon nanopost array (NAPA) structures have been shown to be effective substrates for laser desorption/ionization-mass spectrometry (LDI-MS) and have been used to analyze a variety of samples including peptides, metabolites, drugs, explosives, and intact cells, as well as to image lipids and metabolites in tissue sections. However, no direct comparison has yet been conducted between NAPA-MS and the most commonly used LDI-MS technique, matrix-assisted laser desorption/ionization (MALDI)-MS. In this work, we compare the utility of NAPA-MS to that of MALDI-MS using two common matrices for the analysis of metabolites in cellular extracts and human urine. Considerable complementarity of molecular coverage was observed between the two techniques. Of 178 total metabolites assigned from cellular extracts, 68 were uniquely detected by NAPA-MS and 62 were uniquely detected by MALDI-MS. NAPA-MS was found to provide enhanced coverage of low-molecular weight compounds such as amino acids, whereas MALDI afforded better detection of larger, labile compounds including nucleotides. In the case of urine, a sample largely devoid of higher-mass labile compounds, 88 compounds were uniquely detected by NAPA-MS and 13 by MALDI-MS. NAPA-MS also favored more extensive alkali metal cation adduction relative to MALDI-MS, with the [M + 2Na/K - H] species accounting for as much as 97% of the total metabolite ion signal in positive mode. The capability of NAPA-MS for targeted quantitation of endogenous metabolites in urine via addition of isotopically labeled standards was also examined. Both NAPA-MS and MALDI-MS provided quantitative results in good agreement with one another and the concentrations reported in the literature, as well as good sample-to-sample reproducibility (RSD < 10%).
硅纳米柱阵列(NAPA)结构已被证明是激光解吸/电离-质谱(LDI-MS)的有效基质,并已被用于分析各种样品,包括肽、代谢物、药物、爆炸物和完整细胞,以及对组织切片中的脂质和代谢物进行成像。然而,NAPA-MS 与最常用的 LDI-MS 技术——基质辅助激光解吸/电离(MALDI)-MS 之间尚未进行直接比较。在这项工作中,我们使用两种常用的基质比较了 NAPA-MS 和 MALDI-MS 在细胞提取物和人尿中代谢物分析中的应用。两种技术观察到分子覆盖范围具有相当大的互补性。在从细胞提取物中分配的 178 种总代谢物中,68 种仅由 NAPA-MS 检测到,62 种仅由 MALDI-MS 检测到。发现 NAPA-MS 能够更好地检测低分子量化合物,如氨基酸,而 MALDI 则更有利于检测更大、不稳定的化合物,如核苷酸。在尿液的情况下,由于存在大量高分子量不稳定化合物,NAPA-MS 检测到 88 种独特的化合物,MALDI-MS 检测到 13 种。与 MALDI-MS 相比,NAPA-MS 还更有利于广泛的碱金属阳离子加成,正模式下 [M+2Na/K-H] 物质的比例高达总代谢物离子信号的 97%。我们还检查了 NAPA-MS 通过添加同位素标记标准品对尿内内源性代谢物进行靶向定量的能力。NAPA-MS 和 MALDI-MS 都提供了与彼此以及文献中报道的浓度非常一致的定量结果,以及良好的样品间重现性(RSD<10%)。